Prazak P, Pfisterer M, Osswald S, Buser P, Burkart F
Department of Internal Medicine, University Hospital, Basel, Switzerland.
Eur Heart J. 1996 Feb;17(2):251-7. doi: 10.1093/oxfordjournals.eurheartj.a014842.
In patients with alcoholic cardiomyopathy there is evidence that mild heart failure is reversible if patients abstain from alcohol, but there is no consensus whether the disease is progressive once structural myocardial dilation has evolved. The aim of the present study was to compare the long-term course of congestive heart failure due to alcoholic and idiopathic dilated cardiomyopathy. Of 75 patients with overt congestive heart failure, 23 had alcoholic cardiomyopathy and were compared to 52 patients with idiopathic cardiomyopathy. The mean age was 48 +/- 12 years. Despite medical therapy, heart failure class New York Heart Association III-IV was present in 52% of patients with alcoholic and 47% of patients with idiopathic cardiomyopathy (not significant). Their mean left ventricular ejection fraction was 30 +/- 12% vs 28 +/- 12% and left ventricular end-diastolic volumes were 264 +/- 125 ml and 254 +/- 100 ml respectively (not significant). Overall survival at 1, 5 and 10 years was 100%, 81% and 81% for the group with alcoholic dilated cardiomyopathy and 89%, 48% and 30% for the group with idiopathic cardiomyopathy, respectively (P = 0.041), and the difference was even greater for transplant-free survival P = 0.005). Clinical and invasive signs of left and right heart failure as well as left ventricular dimensions were predictive of a fatal outcome; however, symptom duration and left ventricular volumes were only predictive in patients with idiopathic cardiomyopathy, suggesting that in the two patient groups different mechanisms may lead to death. Mortality in patients with severe congestive heart failure and left ventricular dilatation due to alcoholic cardiomyopathy is significantly lower than that in patients with idiopathic cardiomyopathy and similar degrees of heart failure. Thus, despite structural changes inherent in marked left ventricular dilatation, disease progression in alcoholic dilated cardiomyopathy is different from that in idiopathic cardiomyopathy and thus may have implications for the choice of therapy.
在酒精性心肌病患者中,有证据表明,如果患者戒酒,轻度心力衰竭是可逆的,但对于一旦出现结构性心肌扩张,该疾病是否会进展,目前尚无共识。本研究的目的是比较酒精性和特发性扩张型心肌病所致充血性心力衰竭的长期病程。在75例明显充血性心力衰竭患者中,23例患有酒精性心肌病,并与52例特发性心肌病患者进行比较。平均年龄为48±12岁。尽管进行了药物治疗,但酒精性心肌病患者中52%以及特发性心肌病患者中47%仍处于纽约心脏协会心功能Ⅲ - Ⅳ级(无显著差异)。他们的平均左心室射血分数分别为30±12%和28±12%,左心室舒张末期容积分别为264±125 ml和254±100 ml(无显著差异)。酒精性扩张型心肌病组1年、5年和10年的总体生存率分别为100%、81%和81%,特发性心肌病组分别为89%、48%和30%(P = 0.041),无移植生存率的差异更大(P = 0.005)。左、右心衰竭的临床和有创体征以及左心室大小可预测致命结局;然而,症状持续时间和左心室容积仅在特发性心肌病患者中具有预测性,这表明在这两组患者中,可能有不同的机制导致死亡。因酒精性心肌病导致的严重充血性心力衰竭和左心室扩张患者的死亡率显著低于特发性心肌病且心力衰竭程度相似的患者。因此,尽管存在明显左心室扩张所固有的结构变化,但酒精性扩张型心肌病的疾病进展与特发性心肌病不同,因此可能对治疗选择有影响。